37 results on '"Dagher, A."'
Search Results
2. HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic
3. Wearables in cardiology: Here to stay
4. PO-01-199 ABLATION PARAMETERS AS PREDICTORS OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
5. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY
6. PO-02-219 MODIFIABLE RISK FACTORS PREDICT THE RECURRENCE OF ARRHYTHMIA AFTER PERSISTENT AF ABLATION: ANALYSIS OF THE DECAAF II STUDY
7. PO-01-199 ABLATION PARAMETERS AS PREDICTORS OF ATRIAL ARRHYTHMIA RECURRENCE AFTER PULMONARY VEIN ISOLATION ALONE IN PERSISTENT AF: A DECAAF II SUBSTUDY
8. PO-707-02 SAFETY OF SAME DAY DISCHARGE AFTER LEAD EXTRACTION PROCEDURES
9. PO-699-03 ISCHEMIC STROKE RISK CORRELATES WITH DEGREE OF LEFT ATRIAL FIBROSIS IN ATRIAL FIBRILLATION PATIENTS
10. PO-703-02 DIGITAL HEALTH DEVICE DEMONSTRATES THE LONG-TERM IMPACT OF COVID-19 ON THE CARDIOVASCULAR AND AUTONOMIC SYSTEM
11. BS-516-04 ULTRASTRUCTURAL AND MOLECULAR ORGANIZATION DETERMINE CONDUCTION DIFFERENCES BETWEEN IN ATRIAL AND VENTRICULAR WORKING MYOCARDIUM
12. PO-697-04 WORSE ABLATION-INDUCED SCAR FORMATION ON FIBROTIC TISSUE: A SUB ANALYSIS FROM THE DECAAF II
13. PO-05-143 SHORTER DIAGNOSIS-TO-ABLATION TIME IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION
14. PO-04-143 A PRAGMATIC SCORE FOR BASELINE ATRIAL FIBROSIS PREVALENCE IN PERSISTENT ATRIAL FIBRILLATION PATIENTS UNDERGOING ABLATION
15. PO-03-090 IMPACT OF ABLATION ENERGY AND SUBSTRATE MODIFICATION ON REGRESSION FROM PERSISTENT ATRIAL FIBRILLATION TO PAROXYSMAL ATRIAL FIBRILLATION
16. PO-03-129 LESSONS LEARNED FROM VARIATION IN RADIOFREQUENCY ENERGY DELIVERY SETTINGS IN A MULTICENTER RANDOMIZED TRIAL: IMPORTANCE OF POWER AND DURATION
17. PO-707-02 SAFETY OF SAME DAY DISCHARGE AFTER LEAD EXTRACTION PROCEDURES
18. PO-699-03 ISCHEMIC STROKE RISK CORRELATES WITH DEGREE OF LEFT ATRIAL FIBROSIS IN ATRIAL FIBRILLATION PATIENTS
19. BS-516-04 ULTRASTRUCTURAL AND MOLECULAR ORGANIZATION DETERMINE CONDUCTION DIFFERENCES BETWEEN IN ATRIAL AND VENTRICULAR WORKING MYOCARDIUM
20. B-PO02-070 RACIAL AND SOCIOECONOMIC DISPARITIES IN PATIENTS WITH ATRIAL FIBRILLATION
21. B-PO02-183 MOBILE ELECTROCARDIOGRAM SIGNAL QUALITY ASSESSMENT AND ENHANCEMENT WITH ARTIFICIAL INTELLIGENCE
22. B-PO05-142 ATRIAL FIBRILLATION PATIENT WITH LOW CHA2DS2VASC SCORE MAY STILL BENEFIT FROM ORAL ANTICOAGULATION THERAPY FOR ISCHEMIC STROKE PREVENTION: THE NEED TO REFINE STROKE RISK ASSESSMENT SCORES
23. B-PO05-086 STRUCTURAL AND TISSUE REMODELING OF THE LEFT ATRIUM AND LEFT ATRIAL APPENDAGE AFTER ATRIAL FIBRILLATION ABLATION
24. B-PO04-116 ESOPHAGEAL TEMPERATURE DURING ATRIAL FIBRILLATION ABLATION POORLY PREDICTS ESOPHAGEAL INJURY: AN OBSERVATIONAL STUDY
25. B-PO05-016 SETTLING THE CATHETER ABLATION DISPUTE: ABLATION PARAMETERS DO NOT MATTER
26. B-PO02-182 DISPARITIES IN WEARABLE HEALTH DEVICE AND TELEMEDICINE UNDERSTANDING AND UTILIZATION AMONGST CARDIOLOGY PATIENTS IN NEW ORLEANS
27. PO-703-02 DIGITAL HEALTH DEVICE DEMONSTRATES THE LONG-TERM IMPACT OF COVID-19 ON THE CARDIOVASCULAR AND AUTONOMIC SYSTEM
28. PO-697-04 WORSE ABLATION-INDUCED SCAR FORMATION ON FIBROTIC TISSUE: A SUB ANALYSIS FROM THE DECAAF II
29. Consumer-tech-provider co-doctoring in the digital age: A neglected TRIAD
30. B-PO02-070 RACIAL AND SOCIOECONOMIC DISPARITIES IN PATIENTS WITH ATRIAL FIBRILLATION
31. B-PO02-183 MOBILE ELECTROCARDIOGRAM SIGNAL QUALITY ASSESSMENT AND ENHANCEMENT WITH ARTIFICIAL INTELLIGENCE
32. Consumer-tech-provider co-doctoring in the digital age: A neglected TRIAD
33. B-PO05-086 STRUCTURAL AND TISSUE REMODELING OF THE LEFT ATRIUM AND LEFT ATRIAL APPENDAGE AFTER ATRIAL FIBRILLATION ABLATION
34. B-PO05-016 SETTLING THE CATHETER ABLATION DISPUTE: ABLATION PARAMETERS DO NOT MATTER
35. B-PO04-116 ESOPHAGEAL TEMPERATURE DURING ATRIAL FIBRILLATION ABLATION POORLY PREDICTS ESOPHAGEAL INJURY: AN OBSERVATIONAL STUDY
36. B-PO05-142 ATRIAL FIBRILLATION PATIENT WITH LOW CHA2DS2VASC SCORE MAY STILL BENEFIT FROM ORAL ANTICOAGULATION THERAPY FOR ISCHEMIC STROKE PREVENTION: THE NEED TO REFINE STROKE RISK ASSESSMENT SCORES
37. B-PO02-182 DISPARITIES IN WEARABLE HEALTH DEVICE AND TELEMEDICINE UNDERSTANDING AND UTILIZATION AMONGST CARDIOLOGY PATIENTS IN NEW ORLEANS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.